REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Oximed Clinapal Ltda. (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Oximed Clinapal Ltda. Profile Updated: May 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Oximed Clinapal Ltda. is a company in Colombia, with a head office in Cali. It operates in the Pharmacies and Drug Stores sector. Oximed Clinapal Ltda. was incorporated on July 11, 1985. There are currently 26 (2024) people employed by Oximed Clinapal Ltda.. From the latest financial highlights, Oximed Clinapal Ltda. reported a net sales revenue drop of 6.15% in 2023. Its’ total assets recorded a negative growth of 12.23%. In 2023, Oximed Clinapal Ltda.’s net profit margin increased by 0.76%.

Headquarters
Cl 26 Norte # 3 A - 35
Cali; Valle del Cauca;

Contact Details: Purchase the Oximed Clinapal Ltda. report to view the information.

Basic Information
Total Employees:
Purchase the Oximed Clinapal Ltda. report to view the information.
Outstanding Shares:
Purchase the Oximed Clinapal Ltda. report to view the information.
Incorporation Date:
July 11, 1985
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Oximed Clinapal Ltda. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-6.15%▼
Total operating revenue
-5.63%▼
Operating profit (EBIT)
11.27%▲
EBITDA
7.54%▲
Net Profit (Loss) for the Period
15.26%▲
Total assets
-12.23%▼
Total equity
-1.29%▼
Operating Profit Margin (ROS)
1.49%▲
Net Profit Margin
0.76%▲
Return on Equity (ROE)
1.53%▲
Debt to Equity Ratio
-14.51%▼
Quick Ratio
0.03%▲
Cash Ratio
-0.11%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo